# Reality Check Report: GameForGood Cancer Research Direction

## Validated Core
The strongest defensible element is the explicit, multilayered commitment to "no PHI ever" and end-to-end encryption for all data on volunteer machines. This critical ethical/legal constraint is repeatedly emphasized across all phases (Q2–Q7) and establishes a non-negotiable security boundary that protects patient privacy while enabling the technical approach.

## Critical Gaps
1. **TEE Volunteer Base Size**: The assumption that sufficient volunteers will have TEE‑capable hardware (Intel TDX/AMD SEV‑SNP/Apple M1+) is dangerously optimistic. Most consumer hardware lacks these technologies, potentially reducing the effective volunteer base by 90%+ and making meaningful computational scale impossible.

2. **Partnership Engagement Reliability**: Assuming Gabr Lab will consistently provide timely IP, actively validate results, and commit resources risks academic partnership pitfalls: mismatched priorities, slow review cycles, and resource constraints that could leave volunteer‑generated hits unactionable.

3. **Technical Complexity Underestimation**: Implementing secure, cross‑platform TEE‑backed pharmacological computing (pharmacophore + docking) across Windows/Linux/macOS requires specialized expertise in secure hardware, pharmaceutical computing, and distributed systems that likely exceeds project resources. Any security flaw invalidates the entire premise.

## Next Iteration Hypothesis
Run a constrained technical feasibility spike focusing ONLY on: **Can we successfully run a pharmacophore + docking workflow inside an attested TEE (Intel TDX on Windows/Linux OR Apple Secure Enclave on M1 Mac) with encrypted inputs/outputs, proof‑token generation, and backend verification – using publicly available structures and a small test ligand set (<100 compounds) – before writing volunteer‑facing code or engaging the partnership further?** This tests the core technical assumption (TEE workflow feasibility) with minimal investment.